About Remidio
Remidio is a company based in Bengaluru (India) founded in 2009 by Anand Sivaraman. Remidio has raised $25.01 million across 10 funding rounds from investors including Sun Pharma, KITVEN and Montane Ventures. The company has 135 employees as of April 06, 2024. Remidio offers products and services including Fundus On Phone, Portable Slit Lamp, Medios DR, and Instaref R20. Remidio operates in a competitive market with competitors including Forus Health, Beijing Digital Precision Medical Technology, TowardPi, Topconhealthcare and Wavefront Dynamics, among others.
- Headquarter Bengaluru, India
- Employees 135 as on 06 Apr, 2024
- Founders Anand Sivaraman
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Remidio Innovative Solutions Private Limited
- Date of Incorporation 19 Nov, 2009
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$4.85 M (USD)41.17as on Mar 31, 2023
-
Net Profit
-$1.07 M (USD)-212.46as on Mar 31, 2023
-
EBITDA
-$1.24 M (USD)-637.41as on Mar 31, 2023
-
Total Equity Funding
$25.01 M (USD)
in 10 rounds
-
Latest Funding Round
$18.09 M (USD), Series B
Feb 19, 2023
-
Investors
Sun Pharma
& 26 more
-
Employee Count
135
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Remidio
Remidio offers a comprehensive portfolio of products and services, including Fundus On Phone, Portable Slit Lamp, Medios DR, and Instaref R20.
Device for non-mydriatic fundus imaging and eye health monitoring.
Handheld device for slit imaging in ophthalmic examinations.
AI tool for screening diabetic retinopathy offline.
Aberrometer for eye measurements and diagnostics.
People of Remidio
Unlock access to complete
Funding Insights of Remidio
Remidio has successfully raised a total of $25.01M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $18.09 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Remidio
Remidio has secured backing from 27 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Sun Pharma, KITVEN and Montane Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology startups are funded by Pureland Group through venture capital.
|
Locked | Locked | Locked | |
|
Venture capital fund partnering with entrepreneurs in technology and health sectors.
|
Locked | Locked | Locked | |
|
Deep tech investments in AI and 4th industrial revolution technologies across Europe.
|
Locked | Locked | Locked |
Investor details for Remidio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Remidio
Investment portfolio details for Remidio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Remidio
Detailed financials for Remidio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Remidio Comparisons
Peer comparison for Remidio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Remidio
Remidio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Forus Health, Beijing Digital Precision Medical Technology, TowardPi, Topconhealthcare and Wavefront Dynamics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms
|
|
| Locked | Locked | Locked |
Intraoperative optical molecular imaging navigation solutions are provided.
|
|
| Locked | Locked | Locked |
OCT and optical biometers are developed for ophthalmic disease diagnosis.
|
|
| Locked | Locked | Locked |
Offers medical devices and software for ophthalmic diagnostics and patient care.
|
|
| Locked | Locked | Locked |
Developer of advanced wavefront sensing technology for vision correction. This technology measures imperfections in the eye to optimize visual performance. A key product is a high-resolution wavefront sensor system providing diagnostic data for enhanced vision quality. The company is also developing wavefront-based corrections for various vision-correcting lens platforms.
|
Detailed competitors of Remidio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Remidio
Complete news archive for Remidio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Remidio
Remidio was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Remidio is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Anand Sivaraman is the current CEO of Remidio. They have also founded this company.
Remidio is a funded company, having raised a total of $25.01M across 10 funding rounds to date.
As of Apr 06, 2024, the latest employee count at Remidio is 135.
Annual revenue of Remidio is $4.85M as on Mar 31, 2023.
Remidio was founded in 2009 in Bengaluru, India, focusing on the healthcare sector with an emphasis on ophthalmology. AI and telemedicine are integrated into portable digital devices for eye testing and diagnosis. Products such as Fundus on Phone (FOP-NM), Portable Slit Lamp (PSL-D20), Instaref R20, Anterior Imaging Module (AIM), and Microscope Recording Device (MRD) are offered to support screening operations.
Remidio's top competitors include Forus Health, Cyclops MedTech and Wavefront Dynamics.
Remidio offers Fundus On Phone, Portable Slit Lamp, Medios DR, and Instaref R20.
Remidio has 27 investors. Key investors include Sun Pharma, KITVEN, Montane Ventures, Pureland Group, and Yongfah Capital.
The valuation of Remidio is $67.5M as of Feb 2023.